The CDC Immunization Safety Office is responsible for investigating the safety and effectiveness of all new vaccinations; once an investigation is considered complete, a recommendation is then made to the CDC’s Advisory Committee on Immunization Practices (ACIP) who then determines whether the new vaccine will be added to the current vaccination schedule.
Members of the ACIP committee include physicians such as Dr. Paul Offit, who also serves as the chief of infectious diseases at the Children’s Hospital of Philadelphia.
Offit and other CDC members own numerous patents associated with vaccinations and regularly receive funding for their research work from the very same pharmaceutical companies who manufacture vaccinations which are ultimately sold to the public.
This situation creates an obvious conflict of interest, as members of the ACIP committee benefit financially every time a new vaccination is released to the market.
Each of the 12 members of the CDC’s ACIP Committee has a signicant influence on the health of nearly every member of the American population. Because they are responsible for adding to and/or altering the national vaccine schedule, it is of critical importance that they remain objective and unbiased before determining whether a new vaccination is appropriate for use, particularly in the bodies of vulnerable young children.
Unfortunately, a significant number of ACIP committee members receive direct financial returns when more vaccinations are added to the current schedule. Many own vaccination related patent(s) and/or stock shares of the pharmaceutical companies responsible for supplying new vaccines to the public. Others receive research grant money, funding for their academic departments, or payments for the oversight of vaccine safety trials.
In total, 56 individual patents were found to be owned or shared by one or more members of the ACIP committee or other committees within the CDC.
When prompted with questions pertaining to their financial connections with pharmaceutical companies, most ACIP members claim they are able to remain unbiased despite the rewards they receive every time a new vaccination is recommended to the public.
The rotavirus vaccine… was pulled from the market in 1999, a year after its initial approval.
In 2001, the House Government Reform Committee found that four out of the eight ACIP members who voted to approve the vaccine had direct financial ties to one or more of the pharmaceutical companies who produced the vaccine for public use. Similar situations involving many other vaccinations have been independently documented over the course of nearly 20 years.
If the National Vaccine Injury Compensation Program (NVICP) is amended or repealed, victims of vaccine damage will be legally permitted to file claims directly against vaccine manufacturers and members of the ACIP committee who often have had knowledge of vaccine risks yet continue to recommend their widespread use.